ABSTRACT
Gankyrin is an ankyrin repeat oncoprotein commonly overexpressed in hepatocellular carcinomas. Gankyrin interacts with the S6 proteasomal ATPase and accelerates the degradation of the tumor suppressor Rb. We show here that gankyrin has an antiapoptotic activity in cells exposed to DNA damaging agents. Downregulation of gankyrin induces apoptosis in cells with wild-type p53. In vitro and in vivo experiments revealed that gankyrin binds to Mdm2, facilitating p53-Mdm2 binding, and increases ubiquitylation and degradation of p53. Gankyrin also enhances Mdm2 autoubiquitylation in the absence of p53. Downregulation of gankyrin reduced amounts of Mdm2 and p53 associated with the 26S proteasome. Thus, gankyrin is a cofactor that increases the activities of Mdm2 on p53 and probably targets polyubiquitylated p53 into the 26S proteasome.
Subject(s)
Gene Expression Regulation , Nuclear Proteins/metabolism , Proteasome Endopeptidase Complex/metabolism , Proto-Oncogene Proteins/metabolism , Retinoblastoma Protein/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Ankyrins/metabolism , Apoptosis , Cells, Cultured , Humans , Immunoprecipitation , Mice , Molecular Sequence Data , Neoplasms/metabolism , Neoplasms/pathology , Proteasome Inhibitors , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins c-mdm2 , RNA, Small Interfering/pharmacology , Retinoblastoma Protein/genetics , Tumor Suppressor Protein p53/genetics , Zinc FingersABSTRACT
NF-kappa B is a transcription factor that can protect from or contribute to apoptosis. Here we report identification of HSCO that binds to NF-kappa B and inhibits apoptosis. HSCO mRNA was overexpressed in 20 of 30 hepatocellular carcinomas analyzed. Overexpression of HSCO inhibited caspase 9 activation and apoptosis induced by DNA damaging agents, while it augmented apoptosis induced by TNFalpha. Like I kappa B alpha, HSCO inhibited NF-kappa B activity and abrogated p53-induced apoptosis. However, the underlying mechanism was different. HSCO is a nuclear-cytoplasmic shuttling protein, bound to RelA NF-kappa B, and HSCO sequestered it in the cytoplasm by accelerating its export from the nucleus. These results suggest that overexpression of HSCO suppresses p53-induced apoptosis by preventing nuclear localization of NF-kappa B during signaling and thus contributes to hepatocarcinogenesis.
Subject(s)
Antigens, Neoplasm/genetics , Apoptosis/physiology , Carcinoma, Hepatocellular/metabolism , Cell Nucleus/metabolism , Liver Neoplasms/metabolism , NF-kappa B/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Tumor Suppressor Protein p53/metabolism , Amino Acid Sequence , Animals , Antigens, Neoplasm/immunology , Antigens, Neoplasm/metabolism , Antineoplastic Agents/pharmacology , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Cloning, Molecular , Cytoplasm/metabolism , Drug Resistance, Neoplasm , Electrophoretic Mobility Shift Assay , Fluorescent Antibody Technique , Gene Expression Regulation , Humans , I-kappa B Proteins/metabolism , Liver/metabolism , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Luciferases/metabolism , Mice , Molecular Sequence Data , NF-kappa B/antagonists & inhibitors , Promoter Regions, Genetic , Protein Transport , Sequence Homology, Amino Acid , Thiolester Hydrolases/metabolism , Transcription, Genetic , Tumor Cells, Cultured , Up-RegulationABSTRACT
Traveling neural signals may try to find suitable paths of propagation in cortical circuits. We examined the behavior of electrically evoked signals from primary visual cortex (Oc1) to granular retrosplenial cortex (RSG) in rat brain slices under caffeine application. With continued electrical stimulation, evoked signals propagated from Oc1 to RSG along the upper layer of the secondary visual cortex (Oc2) and agranular retrosplenial cortex (RSA), but on further continuation of stimulation, a new shortcut pathway along the deep layer between Oc2 and RSG was opened. Circuitry changes reduced the signal traveling time by about 40 ms. Cortical neural circuits between Oc1 and RSG may thus have the ability to open a shortcut circuit in a use-dependent manner.
Subject(s)
Evoked Potentials/physiology , Gyrus Cinguli/physiology , Visual Cortex/physiology , Visual Pathways/physiology , Animals , Animals, Newborn , Electric Stimulation/methods , Evoked Potentials/radiation effects , Gyrus Cinguli/anatomy & histology , Gyrus Cinguli/drug effects , In Vitro Techniques , Rats , Rats, Wistar , Spectrum Analysis , Time Factors , Visual Cortex/anatomy & histology , Visual Cortex/drug effects , Visual Pathways/anatomy & histologyABSTRACT
We aimed to elucidate the pathogenesis and evaluate the therapeutic behaviour of patients with an anchored disc phenomenon but a normally positioned disc of the temporomandibular joint (TMJ). Fourteen patients with internal derangement including closed lock of one TMJ were examined. All had normally positioned discs. Synovial fluid was collected from the TMJ by arthrocentesis. Their symptoms, and the protein concentration in the synovial fluid, were evaluated. Their median duration of illness was 3 months (range 0.5-12), and the median protein concentration was low (343 microg/ml; range 36-791). Arthrocentesis was successful in nine. Arthroscopic findings in the five unsuccessful cases showed severe intra-articular adhesions of the TMJ. The main intra-articular pathological feature was the presence of adhesions, which might be affected by low protein concentrations in the synovial fluid. These findings may provide a new treatment in patients with normally positioned discs, despite the small number studied.
Subject(s)
Temporomandibular Joint Disc/pathology , Temporomandibular Joint Disorders/diagnosis , Adolescent , Adult , Aged , Arthralgia/diagnosis , Arthralgia/physiopathology , Arthralgia/therapy , Arthroscopy , Female , Follow-Up Studies , Humans , Joint Dislocations/diagnosis , Joint Dislocations/physiopathology , Joint Dislocations/therapy , Male , Middle Aged , Paracentesis , Proteins/analysis , Range of Motion, Articular/physiology , Synovial Fluid/chemistry , Synovial Fluid/cytology , Synovitis/diagnosis , Synovitis/physiopathology , Synovitis/therapy , Temporomandibular Joint Disc/physiopathology , Temporomandibular Joint Disorders/physiopathology , Temporomandibular Joint Disorders/therapy , Therapeutic Irrigation , Time Factors , Tissue Adhesions/diagnosis , Tissue Adhesions/physiopathology , Tissue Adhesions/therapyABSTRACT
PURPOSE: To compare levels of bradykinin (BK), leukotriene B4 (LTB4), prostaglandin E2 (PGE2), and substance P (SP) between successful and unsuccessful cases of arthrocentesis of temporomandibular joint disorders (TMDs). PATIENTS AND METHODS: A total of 66 joints in 66 patients with TMDs who underwent arthrocentesis were evaluated in this study. Synovial fluid diluted with saline solution was aspirated from the superior joint compartment before arthrocentesis and their concentrations of BK, LTB4, PGE2, and SP were determined by enzyme-linked immunosorbent assay. The differences in the detection rate and concentration of each mediator between successful cases and unsuccessful cases of arthrocentesis were analyzed statistically. RESULTS: Arthrocentesis was successful for 77% (51/66) of the joints. The mean detection rate of LTB4 was significantly (P < .05) higher in the unsuccessful cases (47%) than in the successful cases (16%). The mean concentration of BK was significantly (P < .0005) higher in the unsuccessful cases (425 pg/mL) than in the successful cases (144 pg/mL). There was also a statistical correlation between the detection of LTB4 and PGE2 (P < .01). CONCLUSIONS: Increased levels of BK and LTB4 in the synovial fluid of patients with TMDs may indicate that arthrocentesis is less likely to be a successful treatment.
Subject(s)
Bradykinin/metabolism , Leukotriene B4/metabolism , Paracentesis , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/surgery , Adolescent , Adult , Aged , Bradykinin/analysis , Dinoprostone/analysis , Dinoprostone/metabolism , Female , Humans , Joint Dislocations/metabolism , Joint Dislocations/surgery , Leukotriene B4/analysis , Male , Middle Aged , Osteoarthritis/metabolism , Osteoarthritis/surgery , Pain/metabolism , Prognosis , Statistics, Nonparametric , Substance P/analysis , Substance P/metabolism , Synovial Fluid/chemistryABSTRACT
Gankyrin, a recently discovered oncoprotein, is a promising target for drug therapy because it is overexpressed in most hepatocellular carcinomas. Since gankyrin interacts with MAGE-A4, we made several MAGE-A4 mutants and assessed their effects on cell growth. We found that the C-terminal 107 amino acids of MAGE-A4 (MAGE-A4DeltaN1) induced p53-dependent and p53-independent apoptosis. MAGE-A4DeltaN1 increased the p53 protein level, but decreased the p21(Cip1) transcript and protein levels. During apoptosis Bcl-xL was down-regulated and mitochondrial integrity was disrupted. A yeast two-hybrid screen identified Miz-1 as a MAGE-A4DeltaN1-binding protein. MAGE-A4DeltaN1 was recruited through association with Miz-1 to the p21(Cip1) promoter and down-regulated transcription of p21(Cip1). In 293T cells and U-2 OS cells, full-length MAGE-A4 was processed to generate a C-terminal fragment of 104 amino acids with activities similar to MAGE-A4DeltaN1. Processing was inhibited with a broad range caspase inhibitor Z-VAD-FMK, but not by site-directed mutagenesis of aspartic acids in MAGE-A4, suggesting an indirect involvement of caspase(s) in the processing. The amount of the processed form was increased by exposure of cells to adriamycin. Transduction with a HIV Tat-MAGE-A4DeltaN1 fusion protein suppressed anchorage-independent growth of gankyrin-overexpressing cells in vitro and in vivo. These results demonstrate that the C-terminal fragment of MAGE-A4 induces apoptosis at least partly by binding to Miz-1, and that the fragment may be exploited as an anticancer agent. Furthermore, the finding that a C-terminal fragment with pro-apoptotic activity is generated from full-length MAGE-A4 after genotoxic stress in human cells suggests a novel function for MAGE-A4.
Subject(s)
Antigens, Neoplasm/chemistry , Apoptosis , DNA-Binding Proteins/chemistry , Neoplasm Proteins , Transcription Factors/chemistry , Amino Acid Chloromethyl Ketones/pharmacology , Amino Acid Sequence , Animals , Antigens, Neoplasm/metabolism , COS Cells , Carcinoma, Hepatocellular/metabolism , Caspases/metabolism , Cell Line , Cell Line, Tumor , DNA-Binding Proteins/metabolism , Down-Regulation , Doxorubicin/pharmacology , Enzyme Inhibitors/pharmacology , Female , Gene Products, tat/metabolism , Genes, Reporter , Humans , In Situ Nick-End Labeling , Intracellular Membranes/metabolism , Kruppel-Like Transcription Factors , Membrane Potentials , Mice , Mice, Inbred BALB C , Mice, Nude , Mitochondria/metabolism , Molecular Sequence Data , Mutagenesis, Site-Directed , NIH 3T3 Cells , Plasmids/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid , Time Factors , Transcription Factors/metabolism , Transfection , Tumor Suppressor Protein p53/metabolism , Two-Hybrid System Techniques , bcl-X ProteinABSTRACT
Hepatocellular carcinoma ranks among the most common malignancies in Southeast Asia and South Africa. Although there are many modalities of treatment, the recurrence and metastasis rates are high, and the prognosis is unsatisfactory. Gankyrin, a recently found oncoprotein, is a promising target for drug therapy because it is overexpressed in all studied hepatocellular carcinomas. Gankyrin contains six ankyrin repeats and interacts with Rb, Cdk4, and the S6 ATPase of the 26 S proteasome. In this study, a yeast two-hybrid screen with gankyrin has identified MAGE-A4 as another interacting protein. The interaction, mediated by the C-terminal half of MAGE-A4, was reproduced in mammalian cells. The interaction was specific to MAGE-A4, because other MAGE family proteins structurally similar to MAGE-A4, i.e. MAGE-A1, MAGE-A2, and MAGE-A12, did not bind to gankyrin. MAGE-A4 partially suppressed both anchorage-independent growth in vitro and tumor formation in athymic mice of gankyrin-overexpressing cells. The ability of mutant MAGE-A4 to interact with gankyrin correlated with the ability to suppress the anchorage-independent growth. These results demonstrate that MAGE-A4 binds to gankyrin and suppresses its oncogenic activity. So far, the major focus of studies on the MAGE proteins has been on their potential for cancer immunotherapy. Our results may also shed light on novel functions for MAGE-A proteins.
Subject(s)
Antigens, Neoplasm/metabolism , Neoplasm Proteins , Neoplasms, Experimental/prevention & control , Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins , 3T3 Cells , Amino Acid Sequence , Animals , Antigens, Neoplasm/chemistry , Cell Transformation, Neoplastic/drug effects , Cyclin-Dependent Kinase 4 , Cyclin-Dependent Kinases/metabolism , Female , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Oncogene Proteins/metabolism , Proteasome Endopeptidase Complex , Retinoblastoma Protein/metabolism , Ribosomal Protein S6 Kinases/metabolismABSTRACT
To analyze the important elements for retroviral expression in hepatocytes, cis-acting elements in the U3 region of the long terminal repeat (LTR) of the polycythemic strain of spleen focus-forming virus (SFFVp) were analyzed in a hepatocellular carcinoma cell line. Two cis-acting elements located within the upstream region of the direct repeat, which positively regulated retroviral expression, were identified. Transcription factors NFAT5 and Sp1, which are ubiquitously expressed in a variety of tissues, bound to these elements. To increase specificity without lowering the potency of retroviral expression in hepatocytes, these elements were replaced by a sequence derived from the hepatitis B virus enhancer II region. Novel vectors, SF-Hep3 and SF-Hep5 (SFFVp-based vector for hepatocytes 3 and 5), were developed with these engineered LTRs. The engineered LTRs of these vectors enhanced the retroviral expression only in hepatocellular carcinoma cell lines in vitro. These vectors also increased transgene expression 4- to 9-fold or 3.5- to 5-fold in comparison with a Moloney murine leukemia virus-based vector or a vector containing the wild-type LTR of SFFVp, respectively, in murine hepatocytes in vivo.